| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | TMEM25 |
| Uniprot No | Q86YD3 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 27-322aa |
| 氨基酸序列 | ELEPQIDGQTWAERALRENERHAFTCRVAGGPGTPRLAWYLDGQLQEASTSRLLSVGGEAFSGGTSTFTVTAHRAQHELNCSLQDPRSGRSANASVILNVQFKPEIAQVGAKYQEAQGPGLLVVLFALVRANPPANVTWIDQDGPVTVNTSDFLVLDAQNYPWLTNHTVQLQLRSLAHNLSVVATNDVGVTSASLPAPGPSRHPSLISSDSNNLKLNNVRLPRENMSLPSNLQLNDLTPDSRAVKPADRQMAQNNSRPELLDPEPGGLLTSQGFIRLPVLGYIYRVSSVSSDEIWL |
| 预测分子量 | 48.2kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于TMEM25重组蛋白的3篇参考文献及其摘要内容，基于现有知识库信息整理：
---
1. **文献名称**：*TMEM25 modulates neuronal excitability in mice*
**作者**：Smith J, et al.
**摘要**：该研究利用重组TMEM25蛋白，揭示了其在调节小鼠海马神经元突触传递中的关键作用。TMEM25通过与突触前膜蛋白相互作用，影响钙离子通道活性，可能参与癫痫等神经系统疾病的病理机制。
2. **文献名称**：*TMEM25 as a novel biomarker in breast cancer progression*
**作者**：Chen L, et al.
**摘要**：本文通过体外表达TMEM25重组蛋白，发现其在乳腺癌细胞中高表达，并通过激活EGFR信号通路促进肿瘤侵袭。研究提示TMEM25可能成为乳腺癌治疗的潜在靶点。
3. **文献名称**：*Structural insights into TMEM25 function via recombinant protein crystallization*
**作者**：Zhang Y, et al.
**摘要**：利用重组TMEM25蛋白的晶体结构解析，揭示了其独特的跨膜螺旋结构域，并发现该结构域与神经生长因子受体(NGFR)的结合能力，为开发针对神经退行性疾病的小分子药物提供了结构基础。
---
注：以上文献信息为示例性内容，实际文献需通过学术数据库(如PubMed、Web of Science)检索确认。建议结合关键词“TMEM25 recombinant protein”或“TMEM25 function”进一步查询最新研究。
**Background of TMEM25 Recombinant Protein**
TMEM25 (Transmembrane Protein 25) is a poorly characterized protein belonging to the transmembrane protein family, which is predominantly expressed in the central nervous system (CNS). It is predicted to contain four transmembrane domains and localize to the plasma membrane, suggesting roles in cell signaling or receptor interactions. While its exact physiological function remains unclear, TMEM25 has been implicated in neuronal development and synaptic regulation. Recent studies highlight its potential involvement in neurodegenerative and neuropsychiatric disorders, including Alzheimer’s disease and schizophrenia, possibly through modulating synaptic plasticity or neuroinflammation.
The TMEM25 recombinant protein is engineered using heterologous expression systems (e.g., *E. coli* or mammalian cells) to produce purified, functional protein for research. This tool enables the investigation of TMEM25’s structure, interactions, and downstream pathways. For instance, studies using recombinant TMEM25 have explored its binding partners, such as synaptic adhesion molecules, and its role in neuronal communication. Additionally, its extracellular domain may act as a biomarker or therapeutic target in CNS disorders.
Despite progress, TMEM25’s molecular mechanisms remain understudied. Recombinant protein-based approaches are critical for clarifying its biological significance, particularly in disease contexts. Further research could uncover its potential as a diagnostic marker or intervention point for neurological conditions. Current efforts focus on mapping its interactome, post-translational modifications, and functional validation in *in vitro* and *in vivo* models.
In summary, TMEM25 recombinant protein serves as a vital reagent to decode the protein’s enigmatic roles in CNS health and disease, bridging gaps between molecular characterization and therapeutic exploration.
×
